Targeting inflammatory cells to improve wound healing in diabetic patients
Nanomedicine-Based Targeting of Inflammatory Macrophages in Diabetic Wound Repair
['FUNDING_R01'] · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · NIH-11087620
This study is looking at a new way to help heal wounds in people with diabetes by using tiny drug carriers that deliver medicine right to the cells causing inflammation, which can slow down healing, so that patients can recover better and avoid serious complications.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN (nih funded) |
| Locations | 1 site (CHAMPAIGN, UNITED STATES) |
| Trial ID | NIH-11087620 on ClinicalTrials.gov |
What this research studies
This research investigates how to enhance wound healing in diabetic patients by using nanomedicine to specifically target inflammatory macrophages, which are cells that contribute to chronic inflammation and slow healing. The approach involves developing specialized drug carriers that deliver anti-inflammatory agents directly to these macrophages in wounds, minimizing side effects that can occur with traditional treatments. By focusing on the unique inflammatory environment in diabetic wounds, the research aims to improve the healing process and reduce the risk of complications such as amputations.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with diabetes who are experiencing slow-healing wounds or chronic ulcers.
Not a fit: Patients without diabetes or those with wounds not related to diabetic complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for diabetic wounds, significantly reducing healing times and the risk of amputations.
How similar studies have performed: Previous research has shown promise in using targeted nanomedicine for other inflammatory conditions, suggesting potential success for this novel approach in diabetic wound healing.
Where this research is happening
CHAMPAIGN, UNITED STATES
- UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN — CHAMPAIGN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SMITH, ANDREW MICHAEL — UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
- Study coordinator: SMITH, ANDREW MICHAEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: adult onset diabetes, Adult-Onset Diabetes Mellitus